Original Research

SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway

Ren H, Wang Z, Chen Y, Liu Y, Zhang S, Zhang T, Li Y

OncoTargets and Therapy 2019, 12:2585-2594

Published Date: 8 April 2019